SEND Dataset Quality Control: Best Practices & Recommendations Blog SEND Dataset Quality Control: Best Practices & Recommendations In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for…CertaraApril 25, 2023
How digital communication tools will revolutionize your medical conversation On-Demand Webinar How digital communication tools will revolutionize your medical conversation Medical Affair, Market Access, and Sales & Marketing teams at most of pharmaceutical companies use…CertaraApril 24, 2023
Overcoming CMC challenges in cell and gene therapy: part II Press Coverage Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven…CertaraApril 22, 2023
Using MBMA to run virtual “head-to-head trials” Case Study Using MBMA to run virtual “head-to-head trials” Osteoporosis is common in post-menopausal women. The long-term sequelae of osteoporosis include bone fractures, particularly…CertaraApril 21, 2023
Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech Blog Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…CertaraApril 21, 2023
AMWA 2025 Medical Writing and Communications Conference Conference AMWA 2025 Medical Writing and Communications Conference –CertaraApril 20, 2023
Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis On-Demand Webinar Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis Published research and literature-based content holds valuable insight that can inform clinical trial execution and…CertaraApril 19, 2023
Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development On-Demand Webinar Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…CertaraApril 17, 2023
Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial Case Study Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…CertaraApril 17, 2023
Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program White Paper Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program This white paper focuses on best practices for developing a CMC strategy for orally administered…CertaraApril 13, 2023